Hiv Vaccine Trials Phase 3
Here's a taste of what TheBody.com has to offer on this topic:
Read more »
Vaccination and Enrollment Are Discontinued in Phase II Trials of Merck's Investigational HIV Vaccine CandidateWhitehouse Station, N.J., and Seattle - Vaccination in a phase II clinical trial of Merck & Co., Inc.'s investigational HIV vaccine (V520) is being discontinued because the vaccine was not effective. The announcement was made today by the... Read more »
Read more »
Ask the Experts
The Robert James Frascino AIDS FoundationHi,The news about the limited success of the recent AIDS prevention vaccine trial was unexpected and certainly welcomed, considering the numerous vaccine trial failures over the past decade. However, I agree with Tony Foci that this is not a... Read more »
The Robert James Frascino AIDS FoundationHey there Robby,Well I don't know if dendritic cell therapy is exactly on my bucket list, but I'm certainly a strong proponent of immune-based therapies as a critical piece for the cure of HIV/AIDS. Please feel free to send periodic... Read more »
AIDS Research and Treatment Center of the Treasure CoastThe decision to enter a clinical trial depends on the specific details of the trial. In general, changing from a successful regimen is not unreasonable, but again, the new regimen and goals of switching need to be carefully considered. If you have... Read more »
Rocky Mountain CARESThanks for your post and most importantly, thank you for volunteering to participate in HIV clinical trials. Our whole community owes you collective thanks.Now on to your question. For the purposes of your new treatment regimen, you are... Read more »
Connect With Others
Posted by squanderer, 1 Replyhttp://chi.ucsf.edu/vaccine/vaccines?page=vc-03-00#S1X
Looks like Merck, has a vaccine in Phase II trials.
Read more »
Posted by DUDEThe worldwide search for an HIV vaccine received a boost Thursday as the
National Institute of Allergy and Infectious Diseases (NIAID) announced funding
of nine U.S. clinical units of the new HIV Vaccine Trials Network... Read more »
Posted by SurvivorTanox Reports 48-Week Results from TNX-355 Phase 2 Clinical Trial
New Data Demonstrate Sustained Viral-Load Reductions, Significant Increases in CD4+ Cell Counts in Treatment-Experienced HIV Patients
Company to Discuss Results on Conference Call... Read more »
Posted by Anonymous, 1 ReplyDr. David Ho: "It's terrific. I would say full speed ahead for this particular research program."
The results "are extremely encouraging and what many of us had hoped we's see when the trial started," echoed Dr. Robert Schooley.
"There's still a long... Read more »
Guides for People With HIV